Actively Recruiting

Phase 3
Age: 19Years +
All Genders
NCT07552389

Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

Led by Hanlim Pharm. Co., Ltd. · Updated on 2026-04-27

228

Participants Needed

1

Research Sites

154 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical trial is a randomized, active controlled, double blind, parallel, multi center, phase 3 study to evaluate the efficacy and safety of monotherapy group of HL1113R1 or HL1113R2 versus HL1113 (Fixed dose combination) in patients with essential hypertension and type II diabetes mellitus

CONDITIONS

Official Title

Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult male or female subjects aged 6519 years at the time of written informed consent.
  • Subjects diagnosed with essential hypertension accompanied by type 2 diabetes mellitus.
  • etc.
Not Eligible

You will not qualify if you...

  • Subjects whose blood pressure measured in the selected arm at both screening and randomization meets the following criterion: MSDBP 65110 mmHg
  • Subjects whose blood pressure measured three consecutive times in each arm at intervals of at least 2 minutes at screening shows a difference of 6520 mmHg in SBP and 6510 mmHg in DBP.
  • etc.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Catholic University of Korea Bucheon St. Mary's Hospital

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

K

Kang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here